Literature DB >> 8120451

Identification and characterization of human neutrophil carbonic anhydrase.

A R Campbell1, D L Andress, E R Swenson.   

Abstract

Many functions of polymorphonuclear leukocytes (PMNs) appear to alter and be affected by changes in the intracellular and/or extracellular acid-base milieu, suggesting that carbonic anhydrase (CA) may be important. Although small amounts of CA activity in PMNs have been reported, it has not been characterized fully. We therefore studied isolated mature circulating human PMNs and cultured HL-60 cells, an undifferentiated myelopoietic cell line, and compared these to human red cells (RBCs) for CA activity. Activity and sulfonamide inhibition were measured by a modified micromethod assay. Isoenzyme and total CA concentrations were determined by radioimmunoassay for human isozyme CA I, differential inhibition by MK-927, inhibition by 0.2% sodium dodecyl sulfate (SDS), and quantitative sulfonamide binding. Total CA activity (units/10(6) cells) was 0.04 in PMNs, 0.06 in HL-60 cells, and 0.62 in RBCs. Human PMNs have a total CA concentration of 1.3 microM, of which 0.9 microM is CA I and the remainder is CA II. Total loss of CA activity with 100 microM ethoxzolamide and 0.2% SDS ruled out significant CA III or CA IV activity. Subcellular fractionation of PMNs revealed that all CA activity was cytosolic. The absence of CA activity in mitochondrial and microsomal membrane fractions argues against any mitochondrial CA V or membrane-bound CA IV contribution to total CA activity. Neutrophils contain both CA I and II isozymes in roughly the same proportion as RBCs but at much lower concentrations, suggesting that in the course of maturation the CA content of neutrophils is regulated differently from that in erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8120451     DOI: 10.1002/jlb.55.3.343

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  5 in total

1.  Serum Carbonic Anhydrase 1 is a Biomarker for Diagnosis of Human Schistosoma mansoni Infection.

Authors:  Manal Ibrahim Kardoush; Brian J Ward; Momar Ndao
Journal:  Am J Trop Med Hyg       Date:  2017-04       Impact factor: 2.345

Review 2.  New insights into carbonic anhydrase inhibition, vasodilation, and treatment of hypertensive-related diseases.

Authors:  Erik R Swenson
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

3.  Carbonic anhydrase 2 deficiency leads to increased pyelonephritis susceptibility.

Authors:  David S Hains; Xi Chen; Vijay Saxena; Evan Barr-Beare; Weisi Flemming; Robert Easterling; Brian Becknell; George J Schwartz; Andrew L Schwaderer
Journal:  Am J Physiol Renal Physiol       Date:  2014-08-20

4.  Developmental loss, but not pharmacological suppression, of renal carbonic anhydrase 2 results in pyelonephritis susceptibility.

Authors:  John Ketz; Vijay Saxena; Samuel Arregui; Ashley Jackson; George J Schwartz; Takafumi Yagisawa; Robert L Fairchild; David S Hains; Andrew L Schwaderer
Journal:  Am J Physiol Renal Physiol       Date:  2020-05-11

Review 5.  NETs Are Double-Edged Swords with the Potential to Aggravate or Resolve Periodontal Inflammation.

Authors:  Ljubomir Vitkov; Bernd Minnich; Jasmin Knopf; Christine Schauer; Matthias Hannig; Martin Herrmann
Journal:  Cells       Date:  2020-12-05       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.